ERK/MAPK is essential for endogenous neuroprotection in scn2.2 cells

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Karmarkar, Sumedha W ^a   Bottum, Kathleen M ^a   Krager, Stacey L ^a   Tischkau, Shelley A ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CASPASE 3; GLUTAMIC ACID; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEURITIN; PROTEIN BCL 2; PROTEIN BID; SYNAPTOPHYSIN; UNCLASSIFIED DRUG; BID PROTEIN, RAT; DIZOCILPINE MALEATE; FLAVONOID; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; NEUROPEPTIDE; NEUROPROTECTIVE AGENT; NRN1 PROTEIN, RAT;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL ASSAY; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HYPOTHALAMUS; IMMUNOBLOTTING; MOUSE; NEUROPROTECTION; NICK END LABELING; NONHUMAN; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; RAT; SIGNAL TRANSDUCTION; SUPRACHIASMATIC NUCLEUS; ANIMAL; BIOLOGICAL MODEL; CELL LINE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; NERVE CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; BLOTTING, WESTERN; CASPASE 3; CELL LINE; DIZOCILPINE MALEATE; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLAVONOIDS; GENE EXPRESSION; GLUTAMIC ACID; GPI-LINKED PROTEINS; IMMUNOHISTOCHEMISTRY; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, NEUROLOGICAL; NEURONS; NEUROPEPTIDES; NEUROPROTECTIVE AGENTS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SUPRACHIASMATIC NUCLEUS;

EID: 80051725947     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023493     Document Type: Article

References (81)

1. Bottum K, Poon E, Haley B, Karmarkar S, Tischkau SA, (2010) Suprachiasmatic nucleus neurons display endogenous resistance to excitotoxicity. Exp Biol Med (Maywood) 235: 237-246.
2. Cheng C, Fass DM, Reynolds IJ, (1999) Emergence of excitotoxicity in cultured forebrain neurons coincides with larger glutamate-stimulated [Ca(2+)](i) increases and NMDA receptor mRNA levels. Brain Res 849: 97-108.
3. Choi DW, (1992) Excitotoxic cell death. J Neurobiol 23: 1261-1276.
4. Sinor JD, Du S, Venneti S, Blitzblau RC, Leszkiewicz DN, et al. (2000) NMDA and glutamate evoke excitotoxicity at distinct cellular locations in rat cortical neurons in vitro. J Neurosci 20: 8831-8837.
5. Rusak B, Zucker I, (1979) Neural regulation of circadian rhythms. Physiol Rev 59: 449-526.
6. Reppert SM, Perlow MJ, Ungerleider LG, Mishkin M, Tamarkin L, et al. (1981) Effects of damage to the suprachiasmatic area of the anterior hypothalamus on the daily melatonin and cortisol rhythms in the rhesus monkey. J Neurosci 1: 1414-1425.
7. Reppert SM, Weaver DR, (2002) Coordination of circadian timing in mammals. Nature 418: 935-941.
8. Mosko SS, Moore RY, (1979) Neonatal ablation of the suprachiasmatic nucleus. Effects on the development of the pituitary-gonadal axis in the female rat. Neuroendocrinology 29: 350-361.
9. Mosko S, Moore RY, (1978) Neonatal suprachiasmatic nucleus ablation: absence of functional and morphological plasticity. Proc Natl Acad Sci U S A 75: 6243-6246.
10. Kafka MS, Marangos PJ, Moore RY, (1985) Suprachiasmatic nucleus ablation abolishes circadian rhythms in rat brain neurotransmitter receptors. Brain Res 327: 344-347.
11. Schwartz WJ, Zimmerman P, (1991) Lesions of the suprachiasmatic nucleus disrupt circadian locomotor rhythms in the mouse. Physiol Behav 49: 1283-1287.
12. Sawaki Y, Nihonmatsu I, Kawamura H, (1984) Transplantation of the neonatal suprachiasmatic nuclei into rats with complete bilateral suprachiasmatic lesions. Neurosci Res 1: 67-72.
13. Saitoh Y, Nihonmatsu I, Kawamura H, (1987) Transplantation of the suprachiasmatic nucleus in the rat. Acta Neurochir Suppl (Wien) 41: 41-45.
14. Lehman MN, Silver R, Gladstone WR, Kahn RM, Gibson M, et al. (1987) Circadian rhythmicity restored by neural transplant. Immunocytochemical characterization of the graft and its integration with the host brain. J Neurosci 7: 1626-1638.
15. Tischkau SA, Mitchell JW, Tyan SH, Buchanan GF, Gillette MU, (2003) Ca2+/cAMP response element-binding protein (CREB)-dependent activation of Per1 is required for light-induced signaling in the suprachiasmatic nucleus circadian clock. J Biol Chem 278: 718-723.
16. Tischkau SA, Weber ET, Abbott SM, Mitchell JW, Gillette MU, (2003) Circadian clock-controlled regulation of cGMP-protein kinase G in the nocturnal domain. J Neurosci 23: 7543-7550.
17. Tischkau SA, Gallman EA, Buchanan GF, Gillette MU, (2000) Differential cAMP gating of glutamatergic signaling regulates long-term state changes in the suprachiasmatic circadian clock. J Neurosci 20: 7830-7837.
18. Tischkau SA, Barnes JA, Lin FJ, Myers EM, Barnes JW, et al. (1999) Oscillation and light induction of timeless mRNA in the mammalian circadian clock. J Neurosci 19: RC15.
19. Barnes JW, Tischkau SA, Barnes JA, Mitchell JW, Burgoon PW, et al. (2003) Requirement of mammalian Timeless for circadian rhythmicity. Science 302: 439-442.
20. Prosser RA, McArthur AJ, Gillette MU, (1989) cGMP induces phase shifts of a mammalian circadian pacemaker at night, in antiphase to cAMP effects. Proc Natl Acad Sci U S A 86: 6812-6815.
21. Yoon CH, Kim MJ, Park MT, Byun JY, Choi YH, et al. (2009) Activation of p38 mitogen-activated protein kinase is required for death receptor-independent caspase-8 activation and cell death in response to sphingosine. Mol Cancer Res 7: 361-370.
22. Park MA, Zhang G, Mitchell C, Rahmani M, Hamed H, et al. (2008) Mitogen-activated protein kinase kinase 1/2 inhibitors and 17-allylamino-17-demethoxygeldanamycin synergize to kill human gastrointestinal tumor cells in vitro via suppression of c-FLIP-s levels and activation of CD95. Mol Cancer Ther 7: 2633-2648.
23. Anderson CN, Tolkovsky AM, (1999) A role for MAPK/ERK in sympathetic neuron survival: protection against a p53-dependent, JNK-independent induction of apoptosis by cytosine arabinoside. J Neurosci 19: 664-673.
24. O'Sullivan AW, Wang JH, Redmond HP, (2009) p38 MAP kinase inhibition promotes primary tumour growth via VEGF independent mechanism. World J Surg Oncol 7: 89.
25. Lei K, Davis RJ, (2003) JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis. Proc Natl Acad Sci U S A 100: 2432-2437.
26. Verheij M, Ruiter GA, Zerp SF, van Blitterswijk WJ, Fuks Z, et al. (1998) The role of the stress-activated protein kinase (SAPK/JNK) signaling pathway in radiation-induced apoptosis. Radiother Oncol 47: 225-232.
27. Butcher GQ, Doner J, Dziema H, Collamore M, Burgoon PW, et al. (2002) The p42/44 mitogen-activated protein kinase pathway couples photic input to circadian clock entrainment. J Biol Chem 277: 29519-29525.
28. Mintz EM, Marvel CL, Gillespie CF, Price KM, Albers HE, (1999) Activation of NMDA receptors in the suprachiasmatic nucleus produces light-like phase shifts of the circadian clock in vivo. J Neurosci 19: 5124-5130.
29. Liou SY, Shibata S, Iwasaki K, Ueki S, (1986) Optic nerve stimulation-induced increase of release of 3H-glutamate and 3H-aspartate but not 3H-GABA from the suprachiasmatic nucleus in slices of rat hypothalamus. Brain Res Bull 16: 527-531.
30. Ding JM, Chen D, Weber ET, Faiman LE, Rea MA, et al. (1994) Resetting the biological clock: mediation of nocturnal circadian shifts by glutamate and NO. Science 266: 1713-1717.
31. Shibata S, Watanabe A, Hamada T, Ono M, Watanabe S, (1994) N-methyl-D-aspartate induces phase shifts in circadian rhythm of neuronal activity of rat SCN in vitro. Am J Physiol 267: R360-364.
32. Obrietan K, Impey S, Storm DR, (1998) Light and circadian rhythmicity regulate MAP kinase activation in the suprachiasmatic nuclei. Nat Neurosci 1: 693-700.
33. Cao R, Lee B, Cho HY, Saklayen S, Obrietan K, (2008) Photic regulation of the mTOR signaling pathway in the suprachiasmatic circadian clock. Mol Cell Neurosci 38: 312-324.
34. Villalba M, Bockaert J, Journot L, (1997) Pituitary adenylate cyclase-activating polypeptide (PACAP-38) protects cerebellar granule neurons from apoptosis by activating the mitogen-activated protein kinase (MAP kinase) pathway. J Neurosci 17: 83-90.
35. Persons DL, Yazlovitskaya EM, Cui W, Pelling JC, (1999) Cisplatin-induced activation of mitogen-activated protein kinases in ovarian carcinoma cells: inhibition of extracellular signal-regulated kinase activity increases sensitivity to cisplatin. Clin Cancer Res 5: 1007-1014.
36. Yazlovitskaya EM, Pelling JC, Persons DL, (1999) Association of apoptosis with the inhibition of extracellular signal-regulated protein kinase activity in the tumor necrosis factor alpha-resistant ovarian carcinoma cell line UCI 101. Mol Carcinog 25: 14-20.
37. Cao R, Li A, Cho HY, Lee B, Obrietan K, (2010) Mammalian target of rapamycin signaling modulates photic entrainment of the suprachiasmatic circadian clock. J Neurosci 30: 6302-6314.
38. Hay N, Sonenberg N, (2004) Upstream and downstream of mTOR. Genes Dev 18: 1926-1945.
39. Marais R, Marshall CJ, (1996) Control of the ERK MAP kinase cascade by Ras and Raf. Cancer Surv 27: 101-125.
40. Han BH, Holtzman DM, (2000) BDNF protects the neonatal brain from hypoxic-ischemic injury in vivo via the ERK pathway. J Neurosci 20: 5775-5781.
41. Hetman M, Kanning K, Cavanaugh JE, Xia Z, (1999) Neuroprotection by brain-derived neurotrophic factor is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase. J Biol Chem 274: 22569-22580.
42. Maher P, Dargusch R, Bodai L, Gerard PE, Purcell JM, et al. (2011) ERK activation by the polyphenols fisetin and resveratrol provides neuroprotection in multiple models of Huntington's disease. Hum Mol Genet 20: 261-270.
43. Jiang X, Ai C, Shi E, Nakajima Y, Ma H, (2009) Neuroprotection against spinal cord ischemia-reperfusion injury induced by different ischemic postconditioning methods: roles of phosphatidylinositol 3-kinase-Akt and extracellular signal-regulated kinase. Anesthesiology 111: 1197-1205.
44. Kilic U, Kilic E, Jarve A, Guo Z, Spudich A, et al. (2006) Human vascular endothelial growth factor protects axotomized retinal ganglion cells in vivo by activating ERK-1/2 and Akt pathways. J Neurosci 26: 12439-12446.
45. Yang LC, Zhang QG, Zhou CF, Yang F, Zhang YD, et al. (2010) Extranuclear estrogen receptors mediate the neuroprotective effects of estrogen in the rat hippocampus. PLoS One 5: e9851.
46. Pillaire MJ, Nebreda AR, Darbon JM, (2000) Cisplatin and UV radiation induce activation of the stress-activated protein kinase p38gamma in human melanoma cells. Biochem Biophys Res Commun 278: 724-728.
47. Tovar YRLB, Tapia R, (2010) VEGF protects spinal motor neurons against chronic excitotoxic degeneration in vivo by activation of PI3-K pathway and inhibition of p38MAPK. J Neurochem 115: 1090-1101.
48. Phong MS, Van Horn RD, Li S, Tucker-Kellogg G, Surana U, et al. (2010) p38 mitogen-activated protein kinase promotes cell survival in response to DNA damage but is not required for the G(2) DNA damage checkpoint in human cancer cells. Mol Cell Biol 30: 3816-3826.
49. Eminel S, Klettner A, Roemer L, Herdegen T, Waetzig V, (2004) JNK2 translocates to the mitochondria and mediates cytochrome c release in PC12 cells in response to 6-hydroxydopamine. J Biol Chem 279: 55385-55392.
50. Yustein JT, Li D, Robinson D, Kung HJ, (2000) KFC, a Ste20-like kinase with mitogenic potential and capability to activate the SAPK/JNK pathway. Oncogene 19: 710-718.
51. Mehan S, Meena H, Sharma D, Sankhla R, (2011) JNK: a stress-activated protein kinase therapeutic strategies and involvement in Alzheimer's and various neurodegenerative abnormalities. J Mol Neurosci 43: 376-390.
52. Waetzig V, Herdegen T, (2004) Neurodegenerative and physiological actions of c-Jun N-terminal kinases in the mammalian brain. Neurosci Lett 361: 64-67.
53. Zhou Q, Lam PY, Han D, Cadenas E, (2008) c-Jun N-terminal kinase regulates mitochondrial bioenergetics by modulating pyruvate dehydrogenase activity in primary cortical neurons. J Neurochem 104: 325-335.
54. Zhou Q, Lam PY, Han D, Cadenas E, (2009) Activation of c-Jun-N-terminal kinase and decline of mitochondrial pyruvate dehydrogenase activity during brain aging. FEBS Lett 583: 1132-1140.
55. Waetzig V, Herdegen T, (2003) The concerted signaling of ERK1/2 and JNKs is essential for PC12 cell neuritogenesis and converges at the level of target proteins. Mol Cell Neurosci 24: 238-249.
56. Eminel S, Roemer L, Waetzig V, Herdegen T, (2008) c-Jun N-terminal kinases trigger both degeneration and neurite outgrowth in primary hippocampal and cortical neurons. J Neurochem 104: 957-969.
57. Waetzig V, Zhao Y, Herdegen T, (2006) The bright side of JNKs-Multitalented mediators in neuronal sprouting, brain development and nerve fiber regeneration. Prog Neurobiol 80: 84-97.
58. Fujino T, Lee WC, Nedivi E, (2003) Regulation of cpg15 by signaling pathways that mediate synaptic plasticity. Mol Cell Neurosci 24: 538-554.
59. Marron TU, Guerini V, Rusmini P, Sau D, Brevini TA, et al. (2005) Androgen-induced neurite outgrowth is mediated by neuritin in motor neurones. J Neurochem 92: 10-20.
60. Nedivi E, Wu GY, Cline HT, (1998) Promotion of dendritic growth by CPG15, an activity-induced signaling molecule. Science 281: 1863-1866.
61. Karamoysoyli E, Burnand RC, Tomlinson DR, Gardiner NJ, (2008) Neuritin mediates nerve growth factor-induced axonal regeneration and is deficient in experimental diabetic neuropathy. Diabetes 57: 181-189.
62. Slee EA, Adrain C, Martin SJ, (1999) Serial killers: ordering caspase activation events in apoptosis. Cell Death Differ 6: 1067-1074.
63. Werner AB, de Vries E, Tait SW, Bontjer I, Borst J, (2002) Bcl-2 family member Bfl-1/A1 sequesters truncated bid to inhibit is collaboration with pro-apoptotic Bak or Bax. J Biol Chem 277: 22781-22788.
64. Sedlak TW, Oltvai ZN, Yang E, Wang K, Boise LH, et al. (1995) Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. Proc Natl Acad Sci U S A 92: 7834-7838.
65. Yin XM, Oltvai ZN, Korsmeyer SJ, (1994) BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 369: 321-323.
66. Wang S, Ren P, Li X, Guan Y, Zhang YA, (2011) 17beta-Estradiol Protects Dopaminergic Neurons in Organotypic Slice of Mesencephalon by MAPK-Mediated Activation of Anti-apoptosis Gene BCL2. J Mol Neurosci.
67. Garcia I, Martinou I, Tsujimoto Y, Martinou JC, (1992) Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene. Science 258: 302-304.
68. Allsopp TE, Wyatt S, Paterson HF, Davies AM, (1993) The proto-oncogene bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis. Cell 73: 295-307.
69. Martinou JC, Dubois-Dauphin M, Staple JK, Rodriguez I, Frankowski H, et al. (1994) Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron 13: 1017-1030.
70. Eskes R, Desagher S, Antonsson B, Martinou JC, (2000) Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane. Mol Cell Biol 20: 929-935.
71. Desagher S, Osen-Sand A, Nichols A, Eskes R, Montessuit S, et al. (1999) Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J Cell Biol 144: 891-901.
72. Porterfield VM, Piontkivska H, Mintz EM, (2007) Identification of novel light-induced genes in the suprachiasmatic nucleus. BMC Neurosci 8: 98.
73. Bendova Z, Sumova A, Mikkelsen JD, (2009) Circadian and developmental regulation of N-methyl-d-aspartate-receptor 1 mRNA splice variants and N-methyl-d-aspartate-receptor 3 subunit expression within the rat suprachiasmatic nucleus. Neuroscience 159: 599-609.
74. Clark JP 3rd, Kofuji P, (2010) Stoichiometry of N-methyl-D-aspartate receptors within the suprachiasmatic nucleus. J Neurophysiol 103: 3448-3464.
75. Colwell CS, Khalsa SB, Block GD, (1992) Cellular mechanisms of entrainment. Chronobiol Int 9: 163-179.
76. Colwell CS, Menaker M, (1992) NMDA as well as non-NMDA receptor antagonists can prevent the phase-shifting effects of light on the circadian system of the golden hamster. J Biol Rhythms 7: 125-136.
77. Sattler R, Xiong Z, Lu WY, Hafner M, MacDonald JF, et al. (1999) Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein. Science 284: 1845-1848.
78. Li W, Xue J, Niu C, Fu H, Lam CS, et al. (2007) Synergistic neuroprotection by bis(7)-tacrine via concurrent blockade of N-methyl-D-aspartate receptors and neuronal nitric-oxide synthase. Mol Pharmacol 71: 1258-1267.
79. Buijs RM, Hou YX, Shinn S, Renaud LP, (1994) Ultrastructural evidence for intra- and extranuclear projections of GABAergic neurons of the suprachiasmatic nucleus. J Comp Neurol 340: 381-391.
80. Menger GJ, Lu K, Thomas T, Cassone VM, Earnest DJ, (2005) Circadian profiling of the transcriptome in immortalized rat SCN cells. Physiol Genomics 21: 370-381.
81. Earnest DJ, Liang FQ, Ratcliff M, Cassone VM, (1999) Immortal time: circadian clock properties of rat suprachiasmatic cell lines. Science 283: 693-695.